Search

everythinglearnresearchcommunity

for

Search:↓

Standard treatment for congenital erythropoietic porphyria was ineffective over five years.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.

Mitochondrial therapy and platelet-rich plasma therapy both stimulated hair regrowth in aging mice, with mitochondrial therapy showing similar effectiveness to plasma therapy.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Human pluripotent stem cells could be used to make platelets for medical use, but safety, effectiveness, and cost issues need to be resolved.

Somatostatin may help protect hair follicles from immune attacks.

Stem cell therapy is promising for treating various health conditions, but more research is needed to understand its full potential and address challenges.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Stem cells show promise for hair loss treatment, but no effective product for hair regeneration has been developed yet.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Stem cell therapy, particularly using certain types of cells, shows promise for treating hair loss by stimulating hair growth and development, but more extensive trials are needed to confirm these findings.

Scientists found a way to grow human hair cells in a lab that can create new hair when transplanted.

Human amniotic membrane helps heal skin wounds faster and with less scarring.

Modified rat stem cells on a special scaffold improved blood vessel formation and wound healing in skin substitutes.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Mathematical modeling can improve regenerative medicine by predicting biological processes and optimizing therapy development.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Demodex mites rarely cause scalp infections leading to hair loss, but when they do, treatment is effective.

Umbilical cord cells safely improve healing in long-term nonhealing wounds better than a placebo.

Curcumin applied to the skin can start hair growth in mice.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

New methods for growing skin cells can improve skin grafts by building blood vessels within them.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

NIR-II imaging effectively tracked stem cells that helped repair facial nerve defects in rats.

The enzymes Tet1, Tet2, and Tet3 are important for the development of hair follicles and determining hair shape by controlling hair keratin genes.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.